Dexmedetomidine post-treatment induces neuroprotection via activation of extracellular signal-regulated kinase in rats with subarachnoid haemorrhage
Authors:
- 1 March 2016
- journal article
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 116 (3) , 384-392
Abstract
Dexmedetomidine, a sedative agent, provides neuroprotection when administered during or before brain ischaemia. This study was designed to determine whether dexmedetomidine post-treatment induces neuroprotection against subarachnoid haemorrhage (SAH) and the mechanisms for this effect. Subarachnoid haemorrhage was induced by endovascular perforation to the junction of the right middle and anterior cerebral arteries in adult rats. Dexmedetomidine was applied immediately or 2 h after onset of SAH. Neurological outcome was evaluated 2 days after SAH. Right frontal cortex area 1 was harvested 24 h after SAH for western blotting. Subarachnoid haemorrhage reduced neurological scores and increased brain oedema and blood-brain barrier permeability. These effects were attenuated by dexmedetomidine post-treatment. Neuroprotection by dexmedetomidine was abolished by PD98095, an inhibitor of extracellular signal-regulated kinase (ERK) activation. Phospho-ERK, the activated form of ERK, was increased by dexmedetomidine; this activation was inhibited by PD98095. Dexmedetomidine post-treatment provides neuroprotection against SAH. This effect appears to be mediated by ERK.Keywords
Funding Information
- National Institutes of Health (R01 GM098308)
- International Anaesthesia Research Society,
- 2007 Frontiers in Anaesthesia Research Award
- American Heart Association Mid-Atlantic (10GRNT3900019)
- University of Virginia
This publication has 35 references indexed in Scilit:
- Dexmedetomidine-Induced Sedation Does Not Mimic the Neurobehavioral Phenotypes of Sleep in Sprague Dawley RatSLEEP, 2015
- Developmental Age Influences the Effect of Epidural Dexmedetomidine on Inflammatory Hyperalgesia in Rat PupsAnesthesiology, 2005
- Dexmedetomidine produces its neuroprotective effect via the α2A-adrenoceptor subtypeEuropean Journal of Pharmacology, 2004
- Neuroprotective Effects of Dexmedetomidine in the Gerbil Hippocampus after Transient Global IschemiaAnesthesiology, 1997
- Case-Fatality Rates and Functional Outcome After Subarachnoid HemorrhageStroke, 1997
- Dexmedetomidine Does Not Attenuate Increases in Excitatory Amino Acids After Transient Global Ischemia in the RabbitJournal of Neurosurgical Anesthesiology, 1996
- Neurological Deficit and Extent of Neuronal Necrosis Attributable to Middle Cerebral Artery Occlusion in RatsStroke, 1995
- Neuroprotection by the α2-Adrenoreceptor Agonist Dexmedetomidine in a Focal Model of Cerebral IschemiaAnesthesiology, 1993
- Dexmedetomidine Improves Neurologic Outcome from Incomplete Ischemia in the Rat Reversal by the α2-Adrenergic Antagonist AtipamezoleAnesthesiology, 1991
- Has there been a decline in subarachnoid hemorrhage mortality?Stroke, 1989